Monday, March 28, 2022

mRNA to Treat Long COVID

The Pfizer mRNA vaccine has been successfully used to treat a long COVID patient

he team gave Lester two doses of Pfizer’s mRNA COVID-19 vaccine, separated by about four weeks. Within 14 days of the first dose PCR testing indicated a distinct decrease in the volume of viral material gathered during each nasopharyngeal swab. About six weeks after the second dose Lester tested negative to SARS-CoV-2 for the first time 218 days.


No comments: